Synchronous multiple primary lung cancers with shared EGFR mutation but differential imaging findings and pathological subtypes: A case report.

Lei Su, Yuanbo Li, Tengteng Wang, Leiming Wang, Wei Wang, Xiuqin Wei

Abstract readCase Reports

In one paragraph

Article in Respiratory medicine case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lei SuDepartment of Thoracic Surgery, Xuan Wu Hospital, Capital Medical University, Beijing, China.

Yuanbo LiDepartment of Thoracic Surgery, Xuan Wu Hospital, Capital Medical University, Beijing, China.

Tengteng WangDepartment of Thoracic Surgery, Xuan Wu Hospital, Capital Medical University, Beijing, China.

Leiming WangDepartment of Pathology, Xuan Wu Hospital, Capital Medical University, Beijing, China.

Wei WangDepartment of Pathology, Xuan Wu Hospital, Capital Medical University, Beijing, China.

Xiuqin WeiEndoscopic Center,Beijing Rehabilitation Hospital,Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is a leading cause of cancer mortality worldwide. As the incidence of lung cancer increases in recent years, the number of patients diagnosed with synchronous multiple primary lung cancers (SMPLC) is also rising. SMPLC diagnosis is often made based on the clinical course, imaging findings, and histologic and molecular features. Standard lobectomy is the main therapeutic modality for SMPLC. Because maximum retention of lung function is essential, sublobectomy is also a commonly used surgical strategy when appropriate. The question is how to optimize the sequence of lobectomy and sublobectomy for patients with SMPLC. Thoracoscope lobectomy for the primary lesion plus sublobectomy for the secondary lesions is the most commonly used approach. Here we present a case of SMPLC with sublobectomy followed by lobectomy.

Indexed as

ARMS, amplification refractory mutation systemCT, Computed tomographyEGFR, Epidermal growth factor receptorFEV1, Forced expiratory volume in the first secondFVC, Forced vital capacityLLL, Left lower lobeLUL, left upper lobeLung functionMain driving genesMIA, minimally invasive adenocarcinomaMPLC, Multiple primary lung cancerMVV, Maximum voluntary ventilationNGS, next-generation sequencingNSCLC, non-small cell lung cancerPET-CT, Positron emission tomography-CTpGGO, pure ground glass opacitySMPLC, Synchronous multiple primary lung cancerSUV, Standardized uptake valueSynchronous multiple primary lung cancersThoracoscope surgeryTLC, Total lung capacityVC, Vital capacity

Identifiers

PMID33083221

DOI10.1016/j.rmcr.2020.101244

PMCPMC7552085

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.